Jefferies reiterated its Buy rating and $16 price target on NPS Pharmaceuticals Inc. (NASDAQ: NPSP) following an encouraging physician survey ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE